Our Companies

Q&A with Chris Junker, Former CEO of Complia Health

Chris junker_v2.jpg

Q: Can you explain exactly what your company does?

A: Complia Health is a provider of enterprise and cloud based software to home health agencies, community care agencies, and hospice and residential care agencies in the US, Canada and Australia. Our software is focused on enhancing back office efficiency, and scheduling and coordinating clinical care delivery for our customers’ field and clinical workers. Our software is used daily by over 4,200 customer sites that are managing care for more than three million patients. More than 60,000 office staff and 950,000 care givers rely on our products every day and more than 45,000 residential beds are supported by our systems daily.

Complia Health provides the greatest breadth of support for multi-payer providers of any scale, which includes commercial models, US Medicare and the extremely complex US Medicaid and commercial insurance systems, which vary by state and county.

Q: How did Complia Health get started?

A: A little more than 25 years ago, Complia Health began as an in-house solution at a home care organization in Victoria, British Columbia. Based on an overwhelming demand in the marketplace, the agency decided to take the product into the commercial space.

Since then, the company has grown exponentially by focusing on the unique needs of the homecare industry, enabling quality care and letting the industry drive our innovation and priorities. Today, Complia Health is a global provider of healthcare software solutions that address the needs of multi-discipline care providers by taking care of the business so that our clients can focus on providing care.

Q: What are some of the specific challenges you’ve faced as the company has grown and how have you addressed them?

A: As a global healthcare organization serving three countries and numerous market segments, we are continually challenged to keep pace with the rapidly changing regulatory and compliance environment. To address this, we invest heavily in recruiting and retaining some of the best clinical experts in the industry across Canada, Australia and the United States.

Capitalizing our growth and rapidly taking advantage of the opportunities that present themselves, either as development initiatives or as potential acquisitions, is another challenge we face. It motivated us to seek an equity partner who could not only help us capitalize on the growth potential of an evolving global market, but also provide operational and strategic guidance.

Q: Tell us about your decision to bring in an equity partner.

A: In early 2013, the leadership team determined that as a result of the fragmentation in the market there were a number of opportunities for us to capture market share, either through acquisition or strategic acceleration. We recognized that we could not do this alone and decided that an investor with a broad market perspective was needed to help achieve our growth and profitability objectives. Having worked with a variety of investors in the past, the bar was set very high.

Q: What are the benefits of working with a group like Carrick Capital Partners?

A: Carrick has provided exceptional guidance to us based on their breadth of experience having worked with a number of companies in healthcare and technology. Their focus on adding value to their investments has exceeded our expectations. From day one they were a catalyst for change, aligning the organization around business objectives and immediately working with us to identify our strategic imperatives and options.

With Carrick’s help we have distilled our business down to key performance metrics that drive our decision process and ensure that we are servicing our customer at the highest level. Knowing that Carrick supports our objectives has given us the confidence to think even bigger, which will ultimately result in a greater outcome for all concerned, especially our customers.

By combining our market expertise, outstanding product depth, and dedication to customer service with Carrick’s financial strength and management expertise, we have greatly improved our ability to dominate the homecare market.

Q: What’s next for Complia Health?

A: As the population ages and healthcare costs continue to rise, there will be increased focus on proactively managing client populations in the most comfortable and cost-effective settings available, the client’s home. With Carrick’s help, we intend to continue to capitalize on the fragmentation and consolidation occurring in our industry.

We will be able to accelerate our strategy of becoming the first cloud based homecare platform that supports care giving organizations across the entire continuum of care. Our goal is to be a disruptive force in the home care software arena by empowering our customers to consolidate the many applications they currently use onto the Complia Health platform.

Compilia Health is the leading global provider of technology and expertise for the long-term and post-acute care market
About Carrick Capital Partners
Who We Are
A firm of enterprise software, SaaS, and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Saviynt Logo.jpg
The Saviynt 2020 Release Provides A Single Cloud-Native Identity Platform to Support the Work-from-Anywhere Enterprise, Drive Efficiency, and Reduce Costs
November 18, 2020
Mavenlink Logo.jpg
Professional Services Industry Leader Earns Multiple Accolades for Workplace Culture and Commitment to Employee Well-Being
November 13, 2020
Saama Logo
Pharmaceutical research and development expert with decades of experience Industry visionary with deep knowledge of global regulatory processes and practices 7-member board will continue its focus on advancing and growing the company
November 12, 2020